Keyphrases
Antigen-specific
100%
Breast Cancer Patients
100%
Breast Cancer Xenograft
10%
CD4 T Cells
10%
CD4+
100%
CD8+ T Cell Response
10%
Complementary DNA (cDNA)
100%
ELISPOT
10%
Flow Cytometric Analysis
10%
Foxp3+ T Cells
20%
Human Breast Cancer
20%
Human Breast Cancer Cells
10%
Immune Response
10%
Inducible Costimulator
10%
Interleukin-10
10%
Mammaglobin
100%
Metastatic Cancer
10%
Metastatic Disease
10%
Phase I Clinical Trial
10%
Point Following
10%
Pre-vaccination
30%
Preferential Lysis
10%
Regulatory T Cell(Treg)
10%
Revaccination
20%
SCID Mice
10%
Secretory Proteins
10%
Specific T Cells
10%
T Cells
100%
Treg Frequency
10%
Tumor Immunity
10%
Vaccination
100%
Vaccine Impact
10%
Medicine and Dentistry
Antigen Specificity
100%
Breast Cancer
100%
Cancer Cell
10%
Clinical Trial
10%
Complementary DNA
100%
Cytokine
10%
Cytotoxic T-Cell
10%
Immune Response
10%
Interleukin 10
10%
Mammaglobin A
100%
Metastatic Carcinoma
20%
Regulatory T Cell
10%
SCID Mouse
10%
Secretory Protein
10%
T Cell
100%
T-Cell Response
10%
T-Helper Cell
10%
Tumor Xenograft
10%
Immunology and Microbiology
Antigen Specificity
100%
Cancer Cell
11%
CD4
100%
Cytokine
11%
Cytotoxic T-Cell
11%
Immune Response
11%
Interleukin 10
11%
NOD SCID Mouse
11%
Regulatory T Cell
33%
Secretory Protein
11%
T Cell
100%
T-Helper Cell
11%
Xenograft
11%